Cell and Gene Outsourcing

  1. Delivering Therapies To Patients At Scale And At Speed 10/13/2021

    Resilience is addressing a defining challenge: Biopharmaceutical manufacturing has not kept pace with scientific advancement, preventing new discoveries from reaching patients at speed or scale.

  2. Early Developability And Analytical Toolbox For The Production Of Multi-Chain Biotherapeutics

    In recent years, the number of biotherapeutic molecules requiring more complex assemblies has greatly increased. Typically, these multi-chain molecules are no longer compatible with platform approaches and require a more agile approach to early developability and method development.

  3. Pioneering Solutions That Turn Hope Into Reality

    The number of AAV-mediated therapies in clinical trials continues to rise, increasing demand for doses. A scalable platform is crucial to ensure a seamless transfer from pre-clinical to commercial.

  4. CRISPR Genome Editing Solutions From Discovery To Clinic

    Examine how a partnership leveraging expertise in production for high-quality CRISPR gRNAs as well as cGMP manufacturing is supporting the clinical translation of CRISPR genome editing technologies.

  5. Sustainable Approaches To Oligonucleotide Manufacturing

    An industry expert shares about sustainable Oligo manufacturing approaches that can save time, cost, and resources – while improving purity, quality, and scalability of these promising therapeutics.

  6. The CDMO Value Proposition For Your Autologous Cell Therapy

    This panel session features a decade-long story of partnership in bringing two life-changing gene therapies to market successfully in 2022.

  7. Expertise In Commercial Fill-Finish For More Than 30 Years 8/5/2024

    Examine how a new high-speed aseptic filling line can help bring your product to market with speed and efficiency while ensuring safety and high product quality.

  8. Quantifying Cell Response With Duplex RT-qPCR

    Discover a new potency bioassay using RT-qPCR to assess relative transcription activity, and learn more about the advantages and limitations of transcriptional assays versus reporter gene assays.

  9. Optimizing Viability And Standardization For Clinical Excellence 10/2/2024

    Explore how IntegriCell™ delivers high-quality, manufacture-ready cryopreserved leukopaks, vital for consistent and reliable cell therapy production.

  10. Building A Strong Safety Culture In The Biopharmaceutical Industry 1/25/2025

    Explore how fostering a strong safety culture — rooted in accountability, collaboration, and proactive risk management — can drive operational excellence and long-term success in biopharmaceuticals.